Clinical trial
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors…
NCT00186537 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186537 |
|---|---|
| Title | Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides. |
| Official title | Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals. |
| Lead sponsor | Stanford University, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Insulin Resistance, Hypertriglyceridemia |
| Intervention type | Behavioral, Drug |
| Interventions | Rosiglitazone, Fenofibrate, Weight Loss |
| Enrollment | 47 |
| Start date | Sep 1, 2003 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: